Metabolomic Profiling in the Characterization of Degenerative Bone and Joint Diseases

Overview

Journal Metabolites

Publisher MDPI

Date 2020 Jun 4

PMID 32485832

Citations 21

Authors

Katherine R Swank

Jamie E Furness

Erin A Baker

Corinn K Gehrke

Stephen P Biebelhausen

Kevin C Baker

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis and inflammatory arthropathies are a cause of significant morbidity globally. New research elucidating the metabolic derangements associated with a variety of bone and joint disorders implicates various local and systemic metabolites, which further elucidate the underlying molecular mechanisms associated with these destructive disease processes. In osteoarthritis, atty acid metabolism has been implicated in disease development, both locally and systemically. Several series of rheumatoid arthritis patients have demonstrated overlapping trends related to histidine and glyceric acid, while other series showed similar results of increased cholesterol and glutamic acid. Studies comparing osteoarthritis and rheumatoid arthritis reported elevated gluconic acid and glycolytic- and tricarboxylic acid-related substrates in patients with osteoarthritis, while lysosphingolipids and cardiolipins were elevated only in patients with rheumatoid arthritis. Other bone and joint disorders, including osteonecrosis, intervertebral disc degeneration, and osteoporosis, also showed significant alterations in metabolic processes. The identification of the molecular mechanisms of osteoarthritis and inflammatory arthropathies via metabolomics-based workflows may allow for the development of new therapeutic targets to improve the quality of life in these patient populations.

Citing Articles

Osteopenia Metabolomic Biomarkers for Early Warning of Osteoporosis.

Wang J, Yan D, Wang S, Zhao A, Hou X, Zheng X Metabolites. 2025; 15(1).

PMID: 39852408 PMC: 11767427. DOI: 10.3390/metabo15010066.

Analysis of Key Differential Metabolites in Intervertebral Disc Degeneration Based on Untargeted Metabolomics.

Zhou D, Zhang X, Lv J, Mei Y, Luo Y, Li F JOR Spine. 2025; 8(1):e70032.

PMID: 39781087 PMC: 11707616. DOI: 10.1002/jsp2.70032.

Integrated proteomics and metabolomics analysis of sclerosis-related proteins and femoral head necrosis following internal fixation of femoral neck fractures.

Liu Y, Ma Y, Yang W, Lin Q, Xing Y, Shao H Sci Rep. 2024; 14(1):13207.

PMID: 38851808 PMC: 11162501. DOI: 10.1038/s41598-024-63837-8.

Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification.

Lin C, Tian Q, Guo S, Xie D, Cai Y, Wang Z Molecules. 2024; 29(10).

PMID: 38792060 PMC: 11124072. DOI: 10.3390/molecules29102198.

Changes in the Serum Metabolome in an Inflammatory Model of Osteoarthritis in Rats.

Berenguer N, Canet V, Soler Canet C, Segarra S, Garcia de Carellan A, Serra Aguado C Int J Mol Sci. 2024; 25(6).

PMID: 38542132 PMC: 10970546. DOI: 10.3390/ijms25063158.

References

Yang G, Zhang H, Chen T, Zhu W, Ding S, Xu K . Metabolic analysis of osteoarthritis subchondral bone based on UPLC/Q-TOF-MS. Anal Bioanal Chem. 2016; 408(16):4275-86. DOI: 10.1007/s00216-016-9524-x. View

Giera M, Ioan-Facsinay A, Toes R, Gao F, Dalli J, Deelder A . Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. Biochim Biophys Acta. 2012; 1821(11):1415-24. PMC: 3433634. DOI: 10.1016/j.bbalip.2012.07.011. View

Zhao X, Shah D, Gandhi K, Wei W, Dwibedi N, Webster L . Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States. Osteoarthritis Cartilage. 2019; 27(11):1618-1626. DOI: 10.1016/j.joca.2019.07.002. View

Kosinska M, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U . Sphingolipids in human synovial fluid--a lipidomic study. PLoS One. 2014; 9(3):e91769. PMC: 3960152. DOI: 10.1371/journal.pone.0091769. View

Pontes T, Barbosa A, Silva R, Melo-Junior M, Silva R . Osteopenia-osteoporosis discrimination in postmenopausal women by 1H NMR-based metabonomics. PLoS One. 2019; 14(5):e0217348. PMC: 6541380. DOI: 10.1371/journal.pone.0217348. View

Yang G, Zhao G, Zhang J, Gao S, Chen T, Ding S . Global urinary metabolic profiling of the osteonecrosis of the femoral head based on UPLC-QTOF/MS. Metabolomics. 2019; 15(3):26. DOI: 10.1007/s11306-019-1491-8. View

Lamers R, van Nesselrooij J, Kraus V, Jordan J, Renner J, Dragomir A . Identification of an urinary metabolite profile associated with osteoarthritis. Osteoarthritis Cartilage. 2005; 13(9):762-8. DOI: 10.1016/j.joca.2005.04.005. View

Liu X, Li Q, Sheng J, Hu B, Zhu Z, Zhou S . Unique plasma metabolomic signature of osteonecrosis of the femoral head. J Orthop Res. 2015; 34(7):1158-67. DOI: 10.1002/jor.23129. View

Zhang W, Sun G, Likhodii S, Liu M, Aref-Eshghi E, Harper P . Metabolomic analysis of human plasma reveals that arginine is depleted in knee osteoarthritis patients. Osteoarthritis Cartilage. 2015; 24(5):827-34. DOI: 10.1016/j.joca.2015.12.004. View

10.

Park J, Mendy A, Vieira E . Various Types of Arthritis in the United States: Prevalence and Age-Related Trends From 1999 to 2014. Am J Public Health. 2017; 108(2):256-258. PMC: 5846589. DOI: 10.2105/AJPH.2017.304179. View

11.

Maerz T, Sherman E, Newton M, Yilmaz A, Kumar P, Graham S . Metabolomic serum profiling after ACL injury in rats: A pilot study implicating inflammation and immune dysregulation in post-traumatic osteoarthritis. J Orthop Res. 2018; 36(7):1969-1979. DOI: 10.1002/jor.23854. View

12.

Mickiewicz B, Kelly J, Ludwig T, Weljie A, Wiley J, Schmidt T . Metabolic analysis of knee synovial fluid as a potential diagnostic approach for osteoarthritis. J Orthop Res. 2015; 33(11):1631-8. DOI: 10.1002/jor.22949. View

13.

Briggs M, Kuliwaba J, Muratovic D, Everest-Dass A, Packer N, Findlay D . MALDI mass spectrometry imaging of N-glycans on tibial cartilage and subchondral bone proteins in knee osteoarthritis. Proteomics. 2016; 16(11-12):1736-41. DOI: 10.1002/pmic.201500461. View

14.

Carlson A, Rawle R, Wallace C, Adams E, Greenwood M, Bothner B . Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers. Clin Exp Rheumatol. 2019; 37(3):393-399. View

15.

Lauridsen M, Bliddal H, Christensen R, Danneskiold-Samsoe B, Bennett R, Keun H . 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. J Proteome Res. 2010; 9(9):4545-53. DOI: 10.1021/pr1002774. View

16.

Ma B, Liu J, Zhang Q, Ying H, A J, Sun J . Metabolomic profiles delineate signature metabolic shifts during estrogen deficiency-induced bone loss in rat by GC-TOF/MS. PLoS One. 2013; 8(2):e54965. PMC: 3567117. DOI: 10.1371/journal.pone.0054965. View

17.

Loeser R, Pathmasiri W, Sumner S, McRitchie S, Beavers D, Saxena P . Association of urinary metabolites with radiographic progression of knee osteoarthritis in overweight and obese adults: an exploratory study. Osteoarthritis Cartilage. 2016; 24(8):1479-86. PMC: 4955662. DOI: 10.1016/j.joca.2016.03.011. View

18.

Mirza F, Canalis E . Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol. 2015; 173(3):R131-51. PMC: 4534332. DOI: 10.1530/EJE-15-0118. View

19.

Andonian B, Chou C, Ilkayeva O, Koves T, Connelly M, Kraus W . Plasma MicroRNAs in Established Rheumatoid Arthritis Relate to Adiposity and Altered Plasma and Skeletal Muscle Cytokine and Metabolic Profiles. Front Immunol. 2019; 10:1475. PMC: 6610455. DOI: 10.3389/fimmu.2019.01475. View

20.

Smolenska Z, Smolenski R, Zdrojewski Z . Plasma concentrations of amino acid and nicotinamide metabolites in rheumatoid arthritis--potential biomarkers of disease activity and drug treatment. Biomarkers. 2016; 21(3):218-24. DOI: 10.3109/1354750X.2015.1130746. View